The Current Scenario Of Clinical Pharmacy In Oncology: A Conceptual Perspective

Abstract

Imagine such a vast effect of a disease that its name starts being used to describe any chronically painful and abnormal process—cancer. Millions of individuals worldwide are afflicted by cancer, a complex disease that has several potential causes, including genetics, lifestyle, and environmental factors. For the greatest results, it necessitates early detection and treatment. A major part of pharmaceutical and therapeutic research is dedicated to identifying cancer biomarkers, novel cancer-treatment drugs, and other strategies. Clinical pharmacy is one such field Clinical pharmacy focuses on optimising medication therapy and improving patient outcomes in cancer treatment by collaborating with healthcare providers and patients to develop individualised treatment plans. It also has a crucial function in managing the side effects of cancer drugs and ensuring medication safety.  With the advent of innovative genomic, transcriptomic, and proteomic studies, genetic engineering tools and techniques, and detection platforms like microarray, HPLC, and MS, we can surely reach closer to a world that is adept at treating cancer.